The publication of the preliminary results of a small clinical trial of a new therapy called RNA interference (RNAi) online in the scientific journal Nature is causing quite a stir in the scientific community this week. A team led by Professor Mark E. Davis at Caltech targeted the delivery of a nanoparticle only 70 nanometers … Continue reading RNAi: Send in the Nanobots!
Tag: cancer
Magic Bullets and Monoclonals: A Breakthrough in Bioscience
The Federation of American Societies for Experimental Biology (FASEB) is one of the world’s largest and most influential scientific organizations, representing as it does 23 independent scientific societies and over 90,000 individual scientists. As a coalition that represents tens of thousands of US medical researchers FASEB has policies and positions on all kinds of issues … Continue reading Magic Bullets and Monoclonals: A Breakthrough in Bioscience
From Mouse to Monkey to Humans: The Story of Rituximab
Modern advances in science have meant that our models of diseases have vastly improved. Be that in a dish in the laboratory, a computer simulation or through using a transgenic mouse, there have been developments across the biomedical field that have given us a greater understanding of diseases and how our bodies work. This increase … Continue reading From Mouse to Monkey to Humans: The Story of Rituximab
Can we protect the brain against tumor metastasis?
Brain metastasis that affect at least 20% of cancer patients are a serious problem for doctors seeking to treat cancer and kill thousands of patients every year, being particularly difficult to treat because many anti-cancer drugs cannot cross the blood-brain barrier and because surgery to remove the tumor can often be difficult and risky. Patients … Continue reading Can we protect the brain against tumor metastasis?
Synergy
A claim frequently made by animal rights activists is that by paying for animal research charities and other funding bodies are diverting money from other areas such as clinical research. However the reality is that clinical and animal scientists work together to understand what is going wrong in disease and to illuminate previously unknown aspects … Continue reading Synergy
Taking a BiTE out of non-Hodgkin’s lymphoma
Non-Hodgkin's lymphoma (NHL) is a diverse family of cancers that affect a part of the body's immune system known as the lymphatic system. In NHL white blood cells become cancerous and develop into tumors at key points in the lymphatic system known as the lymph nodes, before spreading to other tissues. About 50,000 Americans develop … Continue reading Taking a BiTE out of non-Hodgkin’s lymphoma
Speaking of Research 